SpringWorks

Money

Germany’s Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B

KEY TAKEAWAYS German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks…

Read More »
Back to top button